Abstract: We examined the expression of VCAM-1 and MAdCAM-1 after bone marrow transplantation (BMT
Introduction
Interactions between hematopoietic tissues and hematopoietic stem/progenitor cells (HSPCs) are essential in regulating the proliferation and differentiation of HSPCs [10, 13, 33] . This regulation appears to be mediated by mutual recognition between adhesion molecules expressed by stromal and vascular endothelial cells (ECs) of hematopoietic tissues and their ligands on HSPCs [26, 29, 35, 37] . Moreover, it is well known that cell adhesion molecules and ligands regulate the migration of HSPCs from the blood stream into the hematopoietic compartment [27] . After BMT following lethally irradiation, donor cells migrate, settle, and proliferate in hematopoietic tissues. In this process, interactions between cell adhesion molecules on ECs and surface anti-gens on donor cells play important roles in homing. Previous studies have shown that various cell adhesion pathways are related to the recruitment of blood cells into bone marrow parenchyma. For example, α 4 β 1 integrin of HSPCs and its receptor, vascular cell adhesion molecule-1 (VCAM-1), play key roles in the homing of HSPCs to bone marrow [15, 30] . Ligands of selectinendothelial cell and selectin-platelet regulate the recruitment of neutrophils [8, 14, 25] , and selectin-endothelial cell ligand and α 4 integrins regulate hematopoietic stem cells [22] . Moreover, it has been reported that α 4 β 1 integrin, α 5 β 1 integrin, β 2 integrin, and sialophorin are expressed on the surface of HSPCs. These factors affect lymphocyte tethering and adherence to ECs in bone marrow [3, 31] and thus may similarly mediate the homing of HSPCs in bone marrow. However, the changes of cell adhesion molecules on ECs and their ligands on donor cells following BMT remain unclear.
Mucosal addressin cell adhesion molecule-1 (MAd-CAM-1) is a homing receptor and is expressed in the high endothelial venules of the mesenteric lymph nodes and Peyer's patch, where it plays a central role in leukocyte migration into these tissues [18] [19] [20] . In mice, MAdCAM-1 is expressed on the cells of the marginal sinus in the spleen [24] . The α 4 β 7 integrin (LPAM-1; lymphocyte Peyer's patch adhesion molecule-1), which is a ligand of MAdCAM-1, is expressed on leukocytes and mediates leukocyte homing to mucosal lymphoid tissues [5] . There have been few reports on the effects of MAdCAM-1 on the homing of hematopoietic cells to the spleen and bone marrow.
To examine the roles of MAdCAM-1 and VCAM-1 on the homing of HSPC, we investigated their expression in ECs of spleen and bone marrow from 1 to 24 h after bone marrow transplantation (BMT). In addition, we examined the influence of α 4 β 7 integrin blockade on cell homing in bone marrow and spleen, using green fluorescent protein (GFP) blood chimeric mice.
Materials and Methods

Animals
All studies were performed in accordance with the guidelines for the care and use of experimental animals of Nagoya University. Male BALB/c mice (8-10 weeks old) were purchased from a commercial breeder, Japan SLC (Hamamatsu, Japan), and C57BL/6N mice were purchased from CLEA Japan (Tokyo, Japan). Transgenic mice with the enhanced green fluorescent protein gene (GFP mice) were a gift from Drs. Okabe and Ikawa, Osaka University, Japan [21, 28] .
Experiment 1 Bone marrow transplantation in BALB/c mice
As hematopoietic cells for transplantation, bone marrow mononuclear cells (BMCs) were obtained from BALB/c mice by flushing the femoral and tibial bones with phosphate-buffered saline (PBS), and the suspension was adjusted to 2 × 10 7 cells/ml (final concentration). Recipient BALB/c mice were exposed to a cumulative dose of about 9.5 Gy of whole body irradiation, using an X-ray irradiator (MBR-1520, Hitachi, Japan). Within 6 h following irradiation, the mice were injected with 1 × 10 7 BMCs through the tail vein. The mice were sacrificed at 1, 3, 6, 12, and 24 h after BMT (4 mice at each point), and spleens and bone marrow were removed for immunoelectron microscopy.
Immunoelectron microscopy
To semi-quantitatively evaluate the expression of VCAM-1 and MAdCAM-1 in vascular ECs, colloidal gold was used in the preparation of specimens for immunoelectron microscopy. Tissues from the transplanted BALB/c mice were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer at 4°C. After fixation, the femurs were decalcified in 5% neutral EDTA solution. The specimens were embedded in OCT compound (Sakura Finetechnical, Tokyo, Japan) and frozen for cryostat sectioning. Sections (18 µm thick) were subjected to immunohistochemistry. Rat anti-mouse VCAM-1 antibody (Santa Cruz Biotechnology, CA, USA) and rat anti-mouse MAdCAM-1 antibody (Santa Cruz Biotechnology) were used as primary antibodies at dilutions of 1:400 and 1:200, respectively. Goat anti-rat IgG antibody conjugated with 5-nm colloidal gold particles was used as the secondary antibody (BBInternational, Cardiff, UK). The small gold particles were then silverenhanced for 5 min at room temperature, using an HQ silver enhancement kit (Nanogold reagent, Nanoprobe Inc., NY, USA). The cryostat sections were post-fixed with 1% OsO 4 for 15 min, dehydrated through graded ethanol solutions, and embedded in Epon. Ultra-thin sections were stained with uranyl acetate for 20 min and observed using a transmission electron microscope (JEM-1210, JEOL, Tokyo, Japan).
Experiment 2 Production of GFP + spleen colonies
For transplantation, a suspension of GFP + BMCs was prepared by using PBS to flush the femoral and tibial bones of C57BL/6N mice carrying the GFP gene (GFP mice), and the suspension was adjusted to 4 × 10 5 cells/ ml (final concentration). To produce GFP + spleen colonies, 2 × 10 5 GFP + BMCs were injected into lethally irradiated (9.8 Gy) C57BL/6 mice within 6 h following irradiation. At 12 days after BMT, the spleens were removed for histological studies and for preparation of spleen cell suspensions. For histological studies, the removed spleens from 5 mice were observed under a fluorescence stereomicroscope (SZX12, Olympus, Japan) to identify GFP + spleen colonies, and these spleens were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer at 4°C, embedded in OCT compound (Sakura Finetechnical), and frozen for cryostat sectioning. Sections (8 µm thick) were counterstained with propidium iodide (Sigma) and observed under a confocal laser scanning microscope (LSM5 PASCAL, Carl Zeiss, Germany). 
Preparation of GFP
Statistical analyses
Colloidal gold particles on the ECs of spleen and bone marrow were counted to evaluate the expression level of cell adhesion molecules. The data are presented as the number of gold particles/10 µm at the luminal surface of the endothelial cell; ten ECs at each stage were selected to determine the average number. For the homing assay, the number of GFP + cells was counted in 0.25 mm
Results
Expression of VCAM-1 and MAdCAM-1 in spleen and bone marrow ECs
Electron microscopy of spleen and bone marrow cells revealed colloidal gold particles showing immune reactions against MAdCAM-1 (Figs. 1A and 1B) and VCAM-1 (Figs. 1C and 1D) . The gold particles appeared on ECs, but some were also recognized on stromal and dendritic cells. The expressions of MAdCAM-1 and VCAM-1 on the endothelial cells of spleen and bone marrow from 1 to 24 h after BMT are shown in Figs. 2   and 3 .
In intact mice, MAdCAM-1 expression on ECs was higher in the bone marrow than in the spleen. In the spleen, MAdCAM-1 was expressed primarily by ECs of the marginal sinus. At 1 h after BMT, MAdCAM-1 expression was almost undetectable, but expression was slightly increased at 3 h after BMT. At 12 h after BMT, MAdCAM-1 expression was slightly decreased again, but expression was markedly increased at 24 h. In bone marrow, MAdCAM-1 expression was decreased from 1 to 6 h after BMT and then was significantly increased the spleen and bone marrow from 1 to 24 h after BMT is shown in Fig. 2 . VCAM-1 expression in spleen ECs was acutely decreased at 1 h but significantly increased at 3 h after BMT. At 6 h, expression was slightly decreased, but VCAM-1 expression was significantly increased at 12 to 24 h after BMT. Especially at 24 h after BMT, VCAM-1 expression was observed at the sinus in the spleen. In bone marrow, VCAM-1 expression was acutely decreased at 1 to 6 h after BMT but was significantly increased at 12 to 24 h. The expression of VCAM-1 in the spleen and bone marrow from 1 to 24 h after BMT is shown in Fig. 3 .
In spleen ECs, MAdCAM-1 expression was less than VCAM-1 expression throughout the experimental period. Moreover, MAdCAM-1 expression was higher in bone marrow than in spleen from 6 to 24 h (Fig. 2) , and VCAM-1 expression was higher in bone marrow than in spleen from 12 to 24 h after BMT (Fig. 3) . 
Formation of GFP + spleen colonies
GFP + BMCs were successfully transplanted into C57BL/6 mice, with no graft versus host reaction. In the 12 days following BMT, several colonies were recognized as protrusions from the surface of the spleen (Fig. 4A) . Under a fluorescence stereomicroscope, all of the colonies emitted green fluorescence, indicating that they were GFP positive (Fig. 4B) . In the spleen sections, proliferated GFP + cells were aggregated in colonies (Fig. 4C) .
Homing of GFP + cells
To examine the influence of α 4 β 7 integrin on cell homing following transplantation, GFP + BMC and GFP + SCC suspensions were treated with anti-α 4 β 7 integrin antibody and transplanted into C57BL/6 mice. At 12 h after the transplantation of untreated GFP + BMCs, the number of homing cells in the spleen was twice that in the bone marrow (Figs. 5A and 5B).
In the group transplanted with GFP + BMCs that had been treated with α 4 β 7 integrin antibody, the numbers of homing cells in the spleen and bone marrow were remarkably decreased (Figs. 5C and 5D ). In the quantitative analysis, the homing cells significantly decreased in spleen (Fig. 7) .
Effect of α 4 β 7 integrin blockade on formation of spleen colonies
To investigate the effect of α 4 β 7 integrin blockade on the formation of spleen colonies, α 4 β 7 integrin-blocked or untreated GFP + BMCs were transplanted into lethally irradiated mice. At 12 days after transplantation, there was no significant difference in the number of spleen colonies between the two transplant groups (Fig. 8) . 
Discussion
In a recent study, Ly6a positive donor cells homing to bone marrow were shown to express sialophorin, α 1 integrin, and α 4 integrin at higher levels than those homing to spleen at 20 h after BMT [32] . This suggests that the expression patterns of surface antigens on donor cells change depending on the homing site [31] . Our previous study revealed that the expression of VCAM-1 and fibronectin on the ECs of fetal hematopoietic tissues changed during the peri-natal period [36] . Both the ligands on the donor cells and the receptors on the ECs changed during extramedullary hematopoiesis.
In the present study, VCAM-1 and MAdCAM-1 expression in bone marrow ECs was decreased at 1 h after BMT and maintained a low level until 6 h. VCAM-1 expression gradually increased from 6 to 24 h after BMT, whereas MAdCAM-1 expression acutely increased until 12 h. Nevertheless, the expression of MAdCAM-1 and VCAM-1 did not increase beyond the intact levels. These data suggest that bone marrow recovers homing ability by 12 h after BMT.
There are few reports on the expression of cell adhesion molecules in ECs of the spleen after post-irradiation BMT. Our study indicates that VCAM-1 expression in the spleen acutely decreased at 1 h following BMT but significantly increased from 3 h onward. MAdCAM-1 expression also increased at 24 h but to a lesser extent than VCAM-1 expression. These results suggest that MAdCAM-1 is not as critical for homing to the spleen as for homing to the bone marrow.
GFP blood chimeric mice have frequently been used for the study of hematopoietic stem cell plasticity [1, 6, 17] . HSPCs are believed to differentiate into blood vessels and replace injured ECs. Thus, transplanted GFP + cells differentiate into ECs as well as hematopoietic cells in the spleen, bone marrow, and liver at 12 days after transplantation [2, 6, 11, 16] . Moreover, GFP + spleen colonies were seen on the surface of the spleen 12 days after BMT. Using GFP chimeric mice, we analyzed the effect that blocking α 4 β 7 integrin had on the homing of transplanted cells. In mice transplanted with untreated BMCs or SCCs, homing cells were more numerous in the spleen than in the bone marrow. These results indicate that both BMCs and SCCs have higher affinity for ECs in the spleen than for ECs in bone marrow. With α 4 β 7 integrin blockade, in BMC-transplanted mice, homing cells were markedly decreased in the spleen and bone marrow, whereas homing cells were unchanged in SCC-transplanted mice. The MAdCAM-1/α 4 β 7 integrin pathway regulates lymphocyte tethering and rolling on ECs of lymphoid tissues [4, 5, 34] . Katayama et al. reported that α 4 β 7 integrin plays a key role in the initial steps of tethering and rolling but was not required for firm adhesion in the bone marrow microvasculature. Our data indicate that α 4 β 7 integrin on the surface of HSPCs derived from bone marrow regulates tethering and rolling on ECs in the spleen and bone marrow. However, colony-forming unit-spleen homing is not regulated by the MAdCAM-1/α 4 β 7 integrin pathway.
Treating bone marrow donor cells with anti-MAd-CAM-1 significantly reduced the number of cells homing to the bone marrow, whereas there was no significant reduction in cells homing to the spleen [23] . A recent study showed that colony-forming unit-spleen homing to bone marrow was unchanged after injection of anti-MAdCAM-1 in wild-type mice [38] . Our results suggest that α 4 β 7 integrin is not important for the homing of SCCs to the bone marrow or spleen and that it does not function in forming spleen colonies.
Some reports have suggested the possibility that α 4 β 7 integrin binds VCAM-1 because of the primary amino acid sequence similarity between VCAM-1 and MAd-CAM-1 [7, 9, 12] . This would mean that α 4 β 7 integrin and α 4 β 7 integrin may compensate between MAdCAM-1 and VCAM-1. Our data indicate that the regulation of homing to the spleen is mediated by a VCAM-1/α 4 β 1 or α 4 β 7 integrin pathway and that homing to bone marrow is mediated by a MAdCAM-1/α 4 β 7 or α 4 β 1 integrin, VCAM-1/α 4 β 1 or α 4 β 7 integrin pathway.
